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Detection of inflammation following renal ischemia by mag- dence of ischemic ARF has been estimated at 115,000
netic resonance imaging. cases per year, and ischemic injury at the time of renal
Background. Determining the disease culprits in human transplantation is thought to be responsible for 20% toacute renal failure (ARF) has been difficult because of the
30% of delayed graft function, which may affect long-paucity of renal biopsies and the lack of noninvasive methods
term graft function [2, 3]. Although a number of mecha-to determine the location or cause of renal injury. Recently,
ultrasmall superparamagnetic iron oxide (USPIO) particles nisms have been identified to play important roles in
have been used to detect inflammation in animal models. animal models of ARF, the exact pathogenetic mecha-
Therefore, we tested if USPIO enhanced magnetic resonance
nism of human ARF is still unknown, and there are noimaging (MRI) could detect inflammation in ischemic ARF in
federal Food and Drug Administration (FDA)-approvedrats.
Methods. Rats were subjected to 40 or 60 minutes of bilateral therapeutic drugs for the prevention or treatment of
ischemia or injected with mercuric chloride. MR images were ARF in humans [2, 4, 5].
obtained before and 24 hours after USPIO injection, and the In animals, leukocyte-endothelial interaction and sub-signal intensity decrease in the outer medulla was measured.
sequent inflammation play an important role in ischemicCells containing iron particles were identified by iron staining
and some forms of toxic ARF. For example, ischemiaand transmission electron microscopy (TEM). Leukocytes
were identified by ED-1 and chloracetate esterase staining. reperfusion injury and cisplatin administration cause re-
Results. Injection of USPIO particles caused a black band lease of inflammatory and cytotoxic mediators, influx of
to appear in the outer medulla at 48, 72, and 120 hours after
inflammatory cells, and plugging of peritubular capillar-ischemia. This band was not detected in normal animals, 24
ies by inflammatory cells [6–8]. The inflammation andhours after ischemia, or 48 hours after mercuric chloride injec-
tion. The signal intensity change in the outer medulla correlated renal injury are inhibited by anti-inflammatory agents,
with serum creatinine and the number of iron particle con- such as anti-intercellular adhesion molecule-1 (ICAM-1)
taining cells. Most infiltrating cells were macrophages, and iron antibodies, -melanocyte-stimulating hormone (MSH),particles were present inside lysosomes of macrophages. US-
interleukin-10 (IL-10), A2A adenosine receptor agonists,PIO injection did not alter renal function in normal or ischemic
animals. and a lipoxin-A analog [9–14].
Conclusion. USPIO-enhanced MRI could detect inflamma- Mercuric chloride–induced ARF is an example of a
tion noninvasively from 48 hours after 40 or 60 minutes of renal pure nephrotoxic ARF; whereas a small amount of in-ischemia in rats. This method might be useful to understand the
flammation does occur, the inflammation is much lesspathogenesis of human ARF and to evaluate the effectiveness
intense than following ischemia, and neither injury norof anti-inflammatory agents.
inflammation is responsive to anti-inflammatory agents
[15]. Despite this large body of evidence in experimental
Acute renal failure (ARF) is still a life-threatening animals, the role of inflammation in human ARF is still
illness whose mortality rate is over 30% [1, 2]. The inci- unknown, in part because of the lack of biopsies in the
early phase of ARF [16].
Magnetic resonance imaging (MRI) can detect bothKey words: renal ischemia, inflammation, magnetic resonance imaging,
contrast agent, USPIO particles, macrophages. anatomic and functional changes in vital organs [17, 18].
Whereas MRI is used clinically to measure renal bloodReceived for publication August 29, 2002
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the proximal straight tubule and can detect dysfunction For the mercuric chloride model, rats were injected
subcutaneously with 4 mg/kg HgCl2 and sacrificed at 48of the proximal straight tubule following cisplatin admin-
hours after injection.istration [19]. Negative enhancing agents, such as dex-
tran-coated ultrasmall particles of iron oxide (USPIO,
Contrast agentsmean diameter 20 to 30 nm), can detect inflammation
Ferumodextran-10 (Combidex) USPIO nanoparticlescaused by cerebral ischemia, arthritis, nephrotoxic ne-
were a kind gift from Advance Magnetics, Inc. (Cam-phritis, and renal transplant rejection in rats [20–23].
bridge, MA, USA), and used under a NIH MaterialSmall dextran-coated iron particles are internalized by
Transfer Agreement. The particles have a 4 to 6 nma wide variety of cells, with preferential uptake by mono-
diameter iron oxide crystal core that is coated with dex-cytes and macrophages [24–26]. Iron particles affect the
tran to give an average diameter of 20 to 30 nm. Particlesmagnetic susceptibility, and hence decrease the MRI
were dissolved in 0.45% saline and 500 mol iron/kg insignal on T2*-weighted images [27]. Larger superpara-
0.4 mL were injected intravenously via the tail vein.magnetic iron oxide (SPIO) particles (mean diameter
150 to 200 nm) are immediately cleared from the circula- MRI
tion by the mononuclear phagocytic system in liver and
Coronal MRI images of both kidneys were obtainedspleen, making them less useful for detection of these
twice in all rats, including a baseline study before ferumo-cells in peripheral tissues. However, the smaller size of
dextran-10 USPIO injection and a second study 24 hoursUSPIO particles allows them to escape detection, thus
later. All sequences were performed with a 4.7 T, 40 cmprolonging their plasma half-life. These properties have
horizontal bore Bruker Biospec System (Bruker Biospin,been exploited to detect tissue inflammation, particularly
Billerica, MA, USA). During the imaging session, ratswhere mononuclear cells are predominant [21–23, 28,
were anesthetized using 1.5% isoflurane, and rectal tem-29], including transplant rejection [20].
perature was maintained at 37  1C, with a heatingBecause noninvasive detection of ARF-induced in-
pad. Multislice gradient-echo images synchronized to re-flammation in either animals, or more important, in hu-
spiratory motion were acquired with a 10 msec echo timemans is currently impossible, we tested the ability of
(TE). Repetition time (TR) was approximately 1 secondUSPIO enhanced MRI to detect inflammation in a rat
and the excitation pulse was adjusted to give maximummodel of ischemic ARF.
signal. Each set consisted of 12, 1 mm slices with no gap
and a 256  256 matrix over a 7 cm field of view.
Signal intensity changes were characterized using re-METHODS
gion of interest (ROI) analysis on a well-centered sliceAnimals
through the right kidney. Region of interests were se-
Male Sprague-Dawley rats were purchased from lected for renal outer medulla, and muscle on the same
Charles River Laboratories (Willmington, MA, USA). slice. The outer medulla ROI was normalized to that of
All animals had free access to water and chow (NIH-07 muscle. The decrease in signal intensity in each animal
Rodent Chow, Zeigler Bros., Inc., Gardens, PA, USA) was calculated according to
before manipulation. Animal care followed the criteria
100  (NIpre – NIpost) / NIpreof the NIH for the care and use of laboratory animals
in research. where NI pre and NIpost are the normalized signal intensity
(to muscle) before and 24 hours after USPIO injection.Injury models
Histologic examinationRats (250 to 300 g) were anesthetized with an intra-
muscular injection of 100 mg/kg ketamine, 10 mg/kg xy- Rat kidney tissue blocks were fixed in 4% paraformal-
lazine, and 1 mg/kg acepromazine. The abdomen was dehyde and processed for paraffin embedding. Two mi-
shaved and the animals were placed on a heating table to cron thick sections were cut with a microtome (RM 2115;
maintain constant body temperature. A midline incision Leica Microsystems Inc., Bannockburn, IL, USA) and
was made and both renal pedicles were clamped for 40 placed on poly-l-lysine (P 8920; Sigma Chemical Co., St.
or 60 minutes. Both kidneys were inspected for ischemia Louis, MO, USA)–coated slides. After drying overnight,
for 2 minutes. After the clamps were removed, the kid- the sections were deparaffinized in xylene, rehydrated
neys were again inspected for restoration of blood flow, through a series of graded alcohols to phosphate-buf-
and 5 mL of warm saline was instilled into abdominal fered saline (PBS). Sections were then blocked for en-
cavity. The abdomen was closed, and the animals were dogenous peroxidase activity with 3% hydrogen perox-
placed in a 29C incubator overnight. At day 1, 2, 3, or ide in methanol for 30 minutes at room temperature,
5, the animals were sacrificed and blood was collected rinsed in PBS, and then reacted with rat ED-1 (Serotec,
for measurement of serum creatinine and both kidneys Oxford, UK) at 1:100 dilution in PBS at 4C overnight,
and the antibody detected by indirect immunoperoxi-were harvested for histologic studies.
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Fig. 2. Percent signal intensity decrease in the outer medulla. Rats were
subjected to 60 minutes bilateral ischemia and given ferumodextran-10
ultrasmall superparamagnetic iron oxide (USPIO) particles at day 4
after ischemia. The percent signal intensity (SI) decrease in the outer
medulla was measured before and 24 hours after ferumodextran-10
USPIO injection. Normal (N  4) and Ischemia (N  9). Data are
shown as mean  SEM. *P  0.01.
Fig. 1. Gradient-echo magnetic resonance imaging (MRI) images be-
fore and 24 hours after injection of ferumodextran-10 ultrasmall super-
paramagnetic iron oxide (USPIO) particles in normal and ischemic
animals. Gradient-echo MRI image of normal rat before (A) or 24 cles. First, we examined MRI images at day 5 after isch-
hours after (B) injection of 500 mol/kg iron ferumodextran-10 USPIO
emia, because previous studies demonstrated that mono-particles. Rats were subjected to 60 minutes bilateral ischemia and
injected with ferumodextran-10 at 96 hours. MRI was taken before (C) nuclear cell infiltration was predominant in recovery
and 24 hours after (D) ferumodextran-10 injection. phase, usually peaking at 3 to 8 days after ischemia. MRI
images taken 24 hours after injection showed a black
band in the outer medulla on day 5 after ischemia (Fig.dase method. In some slides, after the substrate reaction
was finished, the slides were stained with naphthol AS-D 1D). However, this ferumodextran-10–induced black
chloracetate to demonstrate chloracetate esterase in the band was absent in normal animals (Fig. 1B). The black
neutrophils. Neofuchsin solution was prepared according band image pattern was quantitated by measuring the
to the method of Stutte [30], as follows: 1 g of neofuchsin percent decrease in signal intensity in the outer medulla
was dissolved in 25 mL of 2 N hydrochloric acid. Hexa- (see Methods section) and the difference was significant
zotization was performed by allowing the neofuchsin (Fig. 2). Next, we examined the time course of signal
solution to react with an equal volume of a fresh 4% intensity change after ischemia and also in a nephrotoxic
sodium nitrite solution for 1 minute before use. The final injury model. Black bands were detected as early as 48
pH of the incubating medium was 7.4, and incubation hours and then peaked at 72 hours after ischemia (Fig.
time was 45 minutes at room temperature. Slides were 3 B and C), but absent at 24 hours after ischemia, or
washed with tap water, and then counterstained with after HgCl2 injection (Figs. 3A and 4). To assess the
1% hematoxylin for 2 minutes at room temperature, generalizability of these results, we introduced a shorter
dehydrated, cleared in xylene, and mounted with per- ischemic time (40 minutes) in other sets of animals and
mount. found the same black band to appear in outer medulla
Iron particles were detected by Perl’s Prussian blue at day 2, 3, and 5 after ischemia (Fig. 5 A to C). The signal
stain in paraformaldehyde-fixed tissues, and by transmis- intensity decrease in the outer medulla was positively
sion electron microscopy (TEM) on tissue fixed with 2% correlated with the serum creatinine level obtained just
PBS-buffered glutaraldehyde. after the image was taken at day 5 after ischemia (r 
0.78, P  0.01) (Fig. 6).Statistical analysis
All data were expressed as the mean  SEM. Student Histologic studies
t test and Pearson correlation (Sigmastat 2.03) was used
Ischemia caused an influx of inflammatory leukocytesand P value  0.05 was considered as statistically signifi-
into the outer medulla. Using Perl’s Prussian blue stain-cant.
ing, we could observe iron particle–containing cells infil-
trating into the interstitium of outer medulla (Fig. 7A).
RESULTS These cells were not observed in normal animals given
MRI ferumodextran-10 USPIO, or in ischemic animals stud-
ied without particles (data not shown). The number ofMRI images were taken before and 24 hours after
intravenous injection of ferumodextran-10 USPIO parti- Prussian blue–positive cells per high power field (HPF)
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Fig. 3. Time course of magnetic resonance imaging (MRI) images after ferumodextran-10 ultrasmall superparamagnetic iron oxide (USPIO)
injection in ischemic acute renal failure (ARF). Rats were subjected to 60 minutes bilateral ischemia and ferumodextran-10 USPIO particles were
injected at day 0, 1, 2, and 4 after ischemia. MRI images were obtained 24 hours after USPIO injection. (A ) Ischemia/reperfusion at 24 hours
(N  2). (B ) Ischemia/reperfusion at 48 hours (N  4). (C ) Ischemia/reperfusion at 72 hours (N  2). (D ) Ischemia/reperfusion at 120 hours
(N  9). (E ) Mean signal intensity change in the outer medulla was measured at different time points after ischemia.
mine if the infiltrating cells were neutrophils or macro-
phages. Most infiltrating cells on day 5 after ischemia
were ED-1–positive, esterase-negative macrophages
(Fig. 8A). Double staining of ED-1 and esterase showed
only rare esterase-positive, ED-1–negative cells, which
had lobulated nuclei typical of neutrophils (Fig. 8B).
Finally, we detected clustering of iron particles within
the lysosomes of macrophages by TEM (Fig. 7C). We
did not detect any free iron particles in tubular cells or
interstitial cells. Taken together, these results suggest
that iron particles were engulfed by monocyte-macro-
phages, which then decreased the MRI signal intensity
in the outer medulla after ischemic injury.
Fig. 4. Gradient echo magnetic resonance imaging (MRI) image in Effect of ferumodextran-10 USPIO on renal function
HgCl2-induced acute renal failure (ARF) in rats. Rats were injected in ischemic ARFsubcutaneously with 4 mg/kg HgCl2 and MRI image was obtained 24
hours after ferumodextran-10 ultrasmall superparamagnetic iron oxide Because iron particles might decrease renal function
(USPIO) injection at day 2. in ischemic ARF, we determined the effect of ferumo-
dextran-10 USPIO on renal function in three separate
sets of animals. USPIO did not affect serum creatininein the outer medulla correlated with the percent signal
levels in normal animals or in ischemic animals sacrificedintensity decrease in the outer medulla (r  0.96, P 
at 24, 72, or 120 hours after 40 or 60 minutes of bilateral0.01) (Fig. 7B).
We carried out immunohistochemical studies to deter- ischemia (Fig. 9).
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Fig. 5. Time course of magnetic resonance imaging (MRI) images after ferumodextran-10 ultrasmall superparamagnetic iron oxide (USPIO)
injection in 40 minutes ischemia. Rats were subjected to 40 minutes bilateral ischemia and ferumodextran-10 UPSIO particles were injected at
day 1, 2, and 4 after ischemia. MRI images were obtained 24 hours after USPIO injection. (A ) Ischemia/reperfusion at 48 hours (N  2). (B )
Ischemia/reperfusion at 72 hours (N  3). (C ) Ischemia/reperfusion at 120 hours (N  3).
toxic acute renal injury involve an inflammatory re-
sponse characterized by infiltration of leukocytes and
microcirculatory compromise [1, 6]. The role of inflam-
mation in the pathogenesis of ARF is supported by many
studies demonstrating the beneficial effect of antiadhe-
sion therapy [9, 12], or anti-inflammatory agents [10, 11,
13, 14], which reduce both leukocyte infiltration and re-
nal injury. Despite strong evidence from animal studies,
it is unknown if inflammation is also important in human
acute renal injury because of insufficient numbers and
the size of the renal biopsy materials [16]. USPIO parti-
cles have been used both as blood pool agents and to
detect inflammatory foci. Immediately following injec-
Fig. 6. Correlation between renal function and percent signal intensity tion, USPIO particles act as negative blood pool contrast
decrease in the outer medulla. Rats were subjected to 60 minutes bilat- agents in transplantation rejection and glycerol-inducederal ischemia, and injected with ferumodextran-10 ultrasmall superpara-
ARF [33, 34]. However, delayed images obtained 24magnetic iron oxide (USPIO) particles at 4 days after ischemia. Gradi-
ent-echo magnetic resonance imaging (MRI) images were obtained on hours after USPIO injection has been used to detect
day 5. Serum creatinine levels were measured at sacrifice immediately
inflammation [20–23]. Therefore, we tested the abilityafter MRI. Symbols are: () normal; () ischemia/reperfusion at 120
hours. of ferumodextran-10 USPIO particles to detect inflam-
mation in acute renal injury models. We demonstrated
that inflammation following renal ischemia could be de-
tected noninvasively in rats using USPIO-enhancedDISCUSSION
MRI. The three major findings in this study are (1) the
Identification of the correct mechanisms of disease or ferumodextran-10 USPIO–enhanced MRI signal inten-
culprits in human ARF is essential to the development of sity decrease correlated with the amount and location of
effective therapeutic strategies. Several agents have been tissue inflammation, (2) iron particles labeled infiltrating
tested in clinical trials; however, only one agent, N-acetyl macrophages, and (3) ferumodextran-10 USPIO admin-
cysteine, has shown promise to decrease contrast-induced
istration did not affect renal injury or recovery from
acute renal injury in small clinical trials [31, 32]. Whereas
ischemic ARF.there are many potential reasons for the failure of several
vasodilators and growth factors to prevent or treat hu-
Ferumodextran-10 USPIO–enhanced MRI signalman ARF [2], one possibility is that they do not act on the
intensity decrease correlated with the presencecorrect culprit. Determining the correct disease culprit in
and the location of tissue inflammationhuman ARF has been very difficult because of the pau-
Previous studies have determined that USPIO parti-city of pathologic renal biopsy material and difficulties
cles must be injected 24 hours before MRI scanning forin determining the location of renal injury using noninva-
optimal imaging of inflammatory foci [35]. Using thissive methods.
In animals, ischemia/reperfusion or some forms of protocol, we found that ferumodextran-10 USPIO parti-
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Fig. 8. Immunohistochemical detection of leukocytes in ischemic kid-
ney. Rats were subjected to 60 minutes bilateral ischemia and sacrificed
on day 5. (A ) ED-1 immunohistochemistry (magnification 400). (B )
Double staining of ED-1 and naphthol AS-D chloracetate esterase
(arrows indicate ED-1–positive macrophages; arrowhead indicates rare
esterase-positive neutrophil; magnification 250) (inset, esterase-posi-
tive cell, magnification 400).
cles caused a significant decrease in the signal intensity
(i.e., black band) of the outer medulla on day 2, 3, or 5
after 60 minutes ischemia (Figs. 1D and 3 B to D).
Following renal ischemia, mononuclear cells infiltrate
into the outer medulla during the recovery phase, usually
peaking at 3 to 8 days [36–39]. In this study, we were
Fig. 7. Detection of iron in macrophages. Rats were subjected to 60 able to detect the black band in the outer medulla as
minutes bilateral ischemia, and injected with ferumodextran-10 ul- early as 48 hours after ischemia, but not at 24 hours after
trasmall superparamagnetic iron oxide (USPIO) particles at 96 hours,
60 minutes of ischemia (Fig. 3A). And we could alsoand sacrificed at 120 hours after ischemia. (A ) Paraformaldehyde-fixed
kidney tissue was stained with Perl’s Prussian blue (magnification250). detect the same black band in the outer medulla in
(B ) Correlation between the number of Prussian blue–positive cells shorter ischemic time (40 minutes), which was done to
per high power field (HPF) and percent signal intensity decrease in the
assess the generalizability of this method (Fig. 5).outer medulla. Symbols are: () normal; () ischemia/reperfusion at
120 hours. (C ) Ultrastructural detection of iron particles in macrophages We also examined USPIO-enhanced MRI images in
by transmission electron microscopy (magnification 10,000) (inset, mercuric chloride–induced ARF model and no signifi-magnification 70,000). Arrowhead shows iron particles in vesicles.
cant signal intensity change was found (Fig. 4). ThisArrow shows vesicle magnified in insert.
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Fig. 9. Effect of ferumodextran-10 ultrasmall
superparamagnetic iron oxide (USPIO) on re-
nal function in normal rat and following isch-
emia. Blood was taken before () and 24
hours after () ferumodextran-10 USPIO in-
jection in normal rats (N  3), and in three
groups of rats subjected to 40 or 60 minutes
bilateral ischemia (N  3 or 4 per group).
Ferumodextran USPIO particles were in-
jected at 0, 48, or 96 hours and serum creati-
nine was measured at 24, 72, 120 hours. (A )
At 40 minutes ischemia. (B ) At 60 minutes
ischemia.
was perhaps since mercuric chloride causes nephrotoxic particles. Similar to other studies [36–39], we found that
ARF, with only a very small component of inflammatory leukocytes accumulated mainly in interstitium of outer
reaction compared to ischemia [15]. medulla at 3 or 5 days after ischemia. Most of infiltrating
The absence of significant signal intensity decrease in leukocytes were ED-1 positive, but esterase negative (Fig.
outer medulla at 24 hours after ischemia or after mercuric 8A), indicative of macrophages. Only very few esterase-
chloride injection is likely caused by a small number of positive cells were observed in double stained kidney sec-
infiltrating mononuclear cells that is below the detection tion, and these cells had morphologic characteristics of
limit of the MRI. There are a number of ways to increase neutrophils-like lobulated nuclei (Fig. 8B). These findings
the sensitivity of MRI to iron oxide–labeled macro- are in agreement with recent studies that suggest that the
phages. The biggest impact would be to increase image infiltrating cells are predominately monocytes/macro-
resolution. For example, a single iron oxide–labeled cell phages, rather than neutrophils as previously thought [36].
can be detected in vitro if suitable MRI resolution can Perl’s Prussian blue staining revealed that iron con-
be achieved [40]. While this resolution is a challenge to taining cells were located in interstitium of outer medulla
obtain in vivo, improved surface coil detectors and more in ischemic injury animals injected with ferumodextran-10
efficient acquisition strategies might enable higher reso- USPIO particles (Fig. 7A). As a control, iron-containing
lution imaging and thus more sensitive detection of cells. cells were not detected in normal animals injected with
In this study, the location, model specificity, and tem- ferumodextran-10, or ischemic animals injected with ve-
poral course of the MRI signal decrease properly matched hicle. We detected patches of iron particles within the
the leukocyte accumulation seen in this and previous cytoplasm of cells that had morphologic characteristics
studies. of monocytes by TEM (Fig. 7C). The distribution of the
We also observed that the degree of signal intensity iron-containing cells was similar to that of ED-1–positive
decrease positively correlated with renal function on day cells and also to the location of the signal intensity de-
5 after ischemia, indicating a correlation between the crease by MRI. Positive correlation between percent
more severe inflammation and more severe renal injury
signal intensity change and number of Prussian blue–
or delayed recovery (Fig. 6).
positive cells was statistically significant (Fig. 7B). Be-We used a fivefold higher dose (500 mol/kg iron)
cause of technical incompatibilities, we could not per-than recently reported by Ye et al to detect transplant
form double staining for ED-1 and Prussian blue thatrejection across rat strains [18]. The degree of leukocyte
would have provided direct evidence that mononuclearinfiltration is much greater and more widespread in the
cells containing iron particles are responsible for MRIrejection model than following renal ischemia/reperfu-
signal intensity decrease. Instead, we used electron mi-sion injury. In addition, we used a product from a com-
croscopy on outer medullary tissue to confirm that ironpany (ferumodextran-10) compared to their laboratory
particles were located inside lysosomes of macrophagesformation. Although the high dose of ferumodextran-10
(Fig. 6C). Taken together, these results suggest that themay make it difficult to perform similar studies in hu-
marked ferumodextran-10 USPIO–mediated MRI signalmans, a much longer plasma half-life in human (24 hours)
intensity decrease in the outer medulla after renal isch-than in rats (2 to 6 hours) may decrease the dose of
emia comes from infiltrating mononuclear cells that haveferumodextran-10 needed in humans [35].
ingested iron particles.
Iron particles labeled infiltrating macrophages How the iron particles get into the injured kidney is
unknown. Two different mechanisms have been postu-We performed additional studies to identify which
cell(s) were labeled by the ferumodextran-10 USPIO lated. First, iron particles are ingested by peripheral
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monocytes or lymph node macrophages before they mi- normal-looking kidney in acute cyclosporine nephrotox-
grate through the damaged capillary endothelium in re- icity, since the latter lacks an inflammatory component.
sponse to chemokine or cytokine signaling after injury, However, additional studies are needed to determine its
or alternatively, iron particles may enter the interstitium usefulness in the differential diagnosis of posttransplant
across damaged endothelium [41, 42], and are subse- renal dysfunction.
quently engulfed by proliferating local inflammatory
macrophages [29]. The present studies cannot distinguish
CONCLUSIONbetween these two alternatives.
We could detect inflammation in ischemic ARF nonin-
Ferumodextran-10 USPIO did not affect vasively by using ferumodextran-10 USPIO–enhanced
renal function MRI. This noninvasive method might be a useful tool
to increase our understanding of the pathogenesis ofIron has been implicated to play an important role in
human ARF and differentiation of ARF from transplantseveral models of acute renal injury through the genera-
rejection. Currently, ferumodextran-10 USPIO reagentstion of hydroxyl radicals via the Haber-Weiss reaction
are being tested for MRI lymphography in phase IIIor other highly toxic free radicals [43–46]. In addition,
trials, and hence it may soon be possible to apply thisiron-chelating therapy attenuates acute renal injury
method to patients with ARF.[44, 46]. Although prior studies have not shown a cyto-
toxic effect of USPIO particles in vitro and in vivo [28,
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